Barclays’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | – | – | 4388 |
|
|
2024
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4354 |
|
|
2022
Q3 | – | Sell |
-26
| Closed | -$1K | – | 4702 |
|
|
2022
Q2 | $1K | Sell |
26
-73
| -74% | -$2.81K | ﹤0.01% | 4623 |
|
|
2022
Q1 | $3K | Buy |
+99
| New | +$3K | ﹤0.01% | 4632 |
|
|
2020
Q2 | – | Sell |
-19
| Closed | -$9K | – | 3833 |
|
|
2020
Q1 | $9K | Sell |
19
-38
| -67% | -$18K | ﹤0.01% | 3495 |
|
|
2019
Q4 | $11K | Buy |
57
+27
| +90% | +$5.21K | ﹤0.01% | 3720 |
|
|
2019
Q3 | $7K | Sell |
30
-6
| -17% | -$1.4K | ﹤0.01% | 3933 |
|
|
2019
Q2 | $91K | Buy |
36
+17
| +89% | +$43K | ﹤0.01% | 3635 |
|
|
2019
Q1 | $75K | Buy |
+19
| New | +$75K | ﹤0.01% | 3464 |
|
|
2018
Q4 | – | Sell |
-18
| Closed | -$105K | – | 3991 |
|
|
2018
Q3 | $105K | Buy |
18
+14
| +350% | +$81.7K | ﹤0.01% | 3386 |
|
|
2018
Q2 | $13K | Sell |
4
-11
| -73% | -$35.8K | ﹤0.01% | 3799 |
|
|
2018
Q1 | $68K | Buy |
15
+7
| +88% | +$31.7K | ﹤0.01% | 3340 |
|
|
2017
Q4 | $29K | Sell |
8
-14
| -64% | -$50.8K | ﹤0.01% | 3571 |
|
|
2017
Q3 | $105K | Buy |
+22
| New | +$105K | ﹤0.01% | 2686 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 3926 |
|